menu
    • menu

    Company profile for ISA Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ISA Pharmaceuticals B.V. is a clinical-stage immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent virus infections. The Company has built a proprietary immunotherapy platform based on its Synthetic Long Peptide (SLP®) concept and its AMPLIVANT® technology. SLP® immunotherapies are designed to fully harness and direct the body’s own defense mechanisms toward...
    ISA Pharmaceuticals B.V. is a clinical-stage immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent virus infections. The Company has built a proprietary immunotherapy platform based on its Synthetic Long Peptide (SLP®) concept and its AMPLIVANT® technology. SLP® immunotherapies are designed to fully harness and direct the body’s own defense mechanisms towards fighting the disease, either alone or in combination with existing therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ISA PharmaceuticalsNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    J.H. Oortweg 19 NL-2333 CH Leiden The Netherlands
    Telephone
    Telephone
    +31 71 33 22 310
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.isa-pharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ISA reports highlights of randomized Phase 2 cancer vaccine trial in neck cancer
    ISA reports highlights of randomized Phase 2 cancer vaccine trial in neck cancer

    12 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/isa-pharmaceuticals-reports-highlights-of-randomized-phase-2-cancer-vaccine-trial-in-head--neck-cancer-302011313.html

    PR NEWSWIRE
    12 Dec 2023
    Share Share
    ISA's cancer vaccine fails in ph. 2, Regeneron loses interest
    ISA's cancer vaccine fails in ph. 2, Regeneron loses interest

    12 Dec 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/isa-sees-cancer-vaccine-fail-phase-2-fail-loses-regenerons-interest-still-plans-path-market

    James Waldron FIERCE BIOTECH
    12 Dec 2023
    Share Share
    First patient dosed in phase 1 study for chronic hepatitis B treatment
    First patient dosed in phase 1 study for chronic hepatitis B treatment

    31 Aug 2023

    // Betsy Goodfellow PHARMAFILE

    https://pharmafile.com/news/first-patient-dosed-in-phase-1-study-for-chronic-hepatitis-b-treatment/

    Betsy Goodfellow PHARMAFILE
    31 Aug 2023
    Share Share
    First Patient with Chronic Hep B Dosed with ISA104 in First-in-Human Ph 1 Study
    First Patient with Chronic Hep B Dosed with ISA104 in First-in-Human Ph 1 Study

    31 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/first-patient-with-chronic-hepatitis-b-dosed-with-isa104-in-first-in-human-phase-1-study-301913027.html

    PR NEWSWIRE
    31 Aug 2023
    Share Share
    The combination of ISA101b and Libtayo® shows promising results
    The combination of ISA101b and Libtayo® shows promising results

    06 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/the-combination-of-isa101b-and-libtayo-shows-promising-results-in-patients-whose-head-and-neck-cancer-progressed-on-anti-pd1-therapy-301841279.html

    PR NEWSWIRE
    06 Jun 2023
    Share Share
    ISA Pharmaceuticals to Present First Trial Data from Phase II Study of ISA101b
    ISA Pharmaceuticals to Present First Trial Data from Phase II Study of ISA101b

    25 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/isa-pharmaceuticals-to-present-first-clinical-trial-data-from-the-phase-ii-study-of-isa101b-and-libtayo-cemiplimab-combination-in-head-and-neck-cancer-at-the-asco-annual-meeting-2023-301833400.html

    PR NEWSWIRE
    25 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search